Seawolf Therapeutics

Seawolf Therapeutics is a San Diego-based biotechnology company developing DNA-based medicines through its proprietary TRIDENT platform, a redosable lipid nanoparticle (LNP) delivery system that transports DNA payloads into the cell nucleus to drive potent, durable expression of therapeutic proteins. Founded as a Versant Ventures portfolio company, it is advancing a lead metabolic-disease program toward Development Candidate and collaborates with Sanofi on therapies for bleeding disorders. Its investor syndicate includes Versant Ventures, MPM BioImpact, Novartis Venture Fund, Eli Lilly, CRISPR Therapeutics and the philanthropic venture fund Pathway to Cures.

  • Series A
  • Biotechnology
  • Healthtech
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 16, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 16, 2026

    $100M

    Series A

    • MPM BioImpact
    • Sixty Degree Capital
    • Eli Lilly and Company
    • Versant Ventures
    • Alexandria Venture Investments
    • Pathway to Cures
    • Novartis Venture Fund
    • CRISPR Therapeutics AG

    Article coming soon.

Pricing

Research Seawolf Therapeutics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Seawolf Therapeutics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational